Premium
Identification of 8 new mutations in Brazilian families with Marfan syndrome
Author(s) -
Perez Ana B.A.,
Pereira Lygia V.,
Brui Decio,
Zatz Mayana,
PassosBueno Maria Rita
Publication year - 1999
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/(sici)1098-1004(1999)13:1<84::aid-humu15>3.0.co;2-u
Subject(s) - biology , marfan syndrome , identification (biology) , genetics , mutation , computational biology , medicine , gene , botany
Marfan Syndrome (MFS) is a connective tissue disease caused by mutations in the fibrillin‐1 (FBN1) gene. Screening for mutations in all the 65 exons of the FBN1 gene in 34 unrelated patients were performed to compare the efficiency of SSCP versus Heteroduplexanalysis and to verify if the spectrum of mutations in Brazilian patients is similar to the one previously reported. Fourteen different band shifts were detected by SSCP analysis; among these only 6 were also detected through Heteroduplex analysis, suggesting that SSCP analysis was a more efficient method. Except for one, the molecular alteration was confirmed in the remaining 13 cases by sequencing; five of them were neutral polymorphisms and the eight others are new pathogenic mutations, as follows: 5 missense, one nonsense and two deletions leading to a premature termination codon (PTC). All of them are located in EGF‐like‐calcium binding motifs (EGF‐like‐cb). Our findings reinforce that cysteine substitutions and PTC mutations in the region between exons 24‐32 are more likely not to be associated with the neonatal phenotypes. © 1998 Wiley‐Liss, Inc.